CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Safety of add on Interferon-alpha-2a in hepatitis B patients receiving effective nucleos(t)de therapy: Interim results from the German multicenter PADD-ON trial
DOI 10.1055/s-0033-1361051
Bibliografische Angaben
Nachweis in CareLit
Autor:innenMF Sprinzl, A Grambihler, A Ehrlich, J Kittner, M Ebert, S Zeuzem, M Cornberg, J Lohmeyer, F Tacke, C Eisenbach, F Geisler, U Spengler, E Schott, PR Galle
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Treatment of chronic hepatitis B (cHB) with nucleos(t)ide analogues or Interferon-alpha (IFN) monotherapy regularely fails persistent immune control and HBsAg elimination. Hence, we initiated a prospective multicenter trial (PADD-ON) to investigate the addition of IFN to an ongoing nucleos(t)ide treatment. Here we report the study protocol and interim safety data obtained during ongoing study recruitment…
Zitieren
Zitierempfehlung
MF Sprinzl, A Grambihler, A Ehrlich, J Kittner, M Ebert, S Zeuzem, M Cornberg, J Lohmeyer, F Tacke, C Eisenbach, F Geisler, U Spengler, E Schott, PR Galle (2014) Safety of add on Interferon-alpha-2a in hepatitis B patients receiving effective nucleos(t)de therapy: Interim results from the German multicenter PADD-ON trial. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0033-1361051
Mit CareLit weiterarbeiten